Don’t miss the session: “What if rotablator loses the battle?” at #GulfPCR2024 📅 Date: Thursday, December 19, 2024 🕒 Time: 15:25 – 16:55 h 📍 Location: Case Corner 2 Discover how Naviscore, the new player in calcified lesions, is changing the game. Presented by Dr Jeroen Tahon, Interventional Cardiologist at Imelda Hospital. See you there! #iVascular #Naviscore
Info
The purpose of iVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. Its staff has extensive knowledge of biopolymers, coatings, drug delivery, mechanical engineering, medicine and pharmacy. They bring together recognised experience in the development of medical devices and implants. Thanks to the know-how provided by our scientists and technicians and an appropriate investment in technology, iVascular has implemented a vertical integration project allowing it to develop, innovate and produce cardiovascular devices from basic raw materials (plastics, polymers, metals, etc.) to the final device or implant. iVascular possesses and develops its own technologies, which have made possible the vertical integration of each and every one of the processes involved in developing a device, from the earliest design stages through to final production. In this way we guarantee the highest quality standards in all our products. iVascular has a technology center with more than 1000 m² of clean rooms (ISO 7 and ISO 8) and 250 m² of R&D laboratories equipped with the most comprehensive, advanced instrumentation in the biotechnology field. Through its direct and indirect sales network, iVascular is present in more than 70 countries around the world, and is providing with full range of products for interventional cardiology and endovascular procedures. For more information about iVascular, please, visit www.ivascular.global or If you have any questions or comments, we are ready to help you out by an e-mail to [email protected]
- Website
-
http://www.ivascular.global
Externer Link zu iVascular
- Branche
- Herstellung medizinischer Geräte
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Freiburg im Breisgau
- Art
- Personengesellschaft (OHG, KG, GbR etc.)
- Gegründet
- 2010
- Spezialgebiete
- Medical Devices, Polymer Science, Drug Delivery, Cardiovascular devices, Endovascular, Interventional Cardiology, Drug Eluting Stent und Drug Coated Balloon
Orte
Beschäftigte von iVascular
-
Kristel Van Rode
Owner Marketing agency Ju'Cee | Project manager Belgium The Patient Safety Company | Sales & Marketing consultancy iVascular Belux
-
Nacho Benítez Hernández
Jefe de Compras en Ivascular
-
Sara Pich
Clinical&Vigilance Director; Head of Clinical Development and Senior Clinical Project Manager in Global Clinical Trials
-
Mireia Fernández-Carbó
HR Director.
Updates
-
Join us in Dubai on December 18–19, 2024, for the GulfPCR-GIM—the premier event for interventional cardiovascular professionals in the Middle East! 📍Visit us at booth A04 and explore our innovative solutions. #GulfPCR2024 #iVascular #Innovation
-
-
The excellent outcomes of Luminor were presented at the first day of PVI. First the SOL-Japan trial by Dr Soga, that in 1 year follow-up just 1 patient needed reintervention. Later, TINTIN trial 5-year sugroup analysis by Dr. Deloose, demonstrated that the treatment with Luminor + iVolution pro is the perfect combination for complex and long lesions.
-
-
Looking forward to meeting you today at #PVI2024. Join us at booth No. 34 and check out our full scientific program, to learn more about our solutions for the treatment of vascular diseases. #endovascularintervention #PVI2024
-
-
Join us at the Paris Vascular Insights Course from December 12–14, 2024, in Paris, France! 🇫🇷 📍 Stop by our booth to discover our advanced peripheral portfolio and stay tuned for exciting updates on our scientific program. #PVI24 #iVascular #VascularInnovation
-
-
At iVascular, we are deeply committed to fostering social and workplace inclusion. We proudly collaborate with organizations and companies that help us create meaningful opportunities for a vulnerable group, such as: Taller Jeroni de Moragas - CET Fundació Privada Iris Refruiting Prodis Together, we can build a future that values diversity and inclusion in every aspect of life. #DisabilityDay #InclusionMatters #SocialImpact #WorkplaceDiversity
-
-
We are at the ASVS 2024! Today Dr Koen Deloose has presented the needs for a stent in the iliacs, introducing the new generation covered stent: iCover Dr Uthaipaisanwong (King Chulangcorn Memorial Hospital) and Dr Mutirangura (Vajira Hospital) have presented some complex cases with iCover in iliacs and other uses #ASVS2024 #iVascular #VascularInnovation
-
-
iVascular hat dies direkt geteilt
iVascular has announced the initiation of Opal, the first-in-human study with the new embolic liquid Amber, based on a radiopaque biocompatible copolymer. Opal is a prospective, single-arm, multicentre study with a sample size of 70 patients requiring peripheral embolization. Sofía Valle https://lnkd.in/eiZxSjmd
-
A cutting-edge PCI workshop was recently held at Izola General Hospital, Slovenia, led by the esteemed Dr Jurij Avramovic Gregoric. The session focused on plaque modification techniques and advanced #DCB treatments, offering practical insights into treating complex lesions. 🌍 Participants from Ukraine, Bulgaria, Belgium, and Italy had the opportunity to witness challenging cases expertly managed with #Naviscore and #EssentialPro, showcasing their clinical value in real-world applications. At iVascular, we are committed to supporting the education and training of physicians worldwide, ensuring they have access to the latest techniques and technologies to enhance patient care. A special thanks to Dr Avramovic and our partner in Slovenia, Thomy FE, for their outstanding support and collaboration! 📌 Discover more about the innovative iVascular coronary portfolio: https://lnkd.in/e5NBCNfE #iVascular #PCI #InterventionalCardiology #Innovation #MedicalEducation
-
-
Today, we proudly announce #ISALAB, our future lab dedicated to the memory of our late Chief Technical Officer, Mrs Isabel Pérez Serrano. Isabel’s groundbreaking contributions to coronary intervention, endovascular intervention, and neuroradiology—along with her creation of 30 medical devices in just 13 years—have left an indelible mark on iVascular and the medical field. She will always be a main pillar of our family. ISALAB will carry on her legacy, serving as a space for innovation and collaboration, just as she inspired in all of us. Thank you, Isabel. This is our tribute to your vision and passion. #iVascular #MedicalInnovation
-